Study to Evaluate Pharmacokinetics, Safety, and Tolerability Ildong COL-144 Tablet in Korean Healthy Volunteers
Clinical trial NCT03937648 · UNKNOWN
Trial details
- NCT number
- NCT03937648
- Sponsor
- IlDong Pharmaceutical Co Ltd
- Status
- UNKNOWN
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2019-08-01
- Primary completion
- 2019-10-31
- Enrollment
- 64
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.